These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8874660)

  • 1. Effects of interleukin (IL)-3 and IL-5 on human eosinophil degranulation induced by complement components C3a and C5a.
    Takafuji S; Tadokoro K; Ito K
    Allergy; 1996 Aug; 51(8):563-8. PubMed ID: 8874660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degranulation from human eosinophils stimulated with C3a and C5a.
    Takafuji S; Tadokoro K; Ito K; Dahinden CA
    Int Arch Allergy Immunol; 1994; 104 Suppl 1(1):27-9. PubMed ID: 8156000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of physiologic soluble agonists on leukotriene C4 production and degranulation by human eosinophils.
    Takafuji S; Tadokoro K; Ito K; Dahinden CA
    Int Arch Allergy Immunol; 1995; 108 Suppl 1():36-8. PubMed ID: 7549519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophil degranulation in the presence of bronchial epithelial cells. Effect of cytokines and role of adhesion.
    Takafuji S; Ohtoshi T; Takizawa H; Tadokoro K; Ito K
    J Immunol; 1996 May; 156(10):3980-5. PubMed ID: 8621939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophil degranulation in the presence of lung fibroblasts.
    Takafuji S; Shoji S; Ito K; Yamamoto K; Nakagawa T
    Int Arch Allergy Immunol; 1998 Sep; 117 Suppl 1():52-4. PubMed ID: 9758898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of IL-3, IL-5, and GM-CSF on normal human eosinophil and neutrophil C3b-induced degranulation.
    Carlson M; Peterson C; Venge P
    Allergy; 1993 Aug; 48(6):437-42. PubMed ID: 8238799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phorbol ester-induced degranulation in adherent human eosinophil granulocytes is dependent on CD11/CD18 leukocyte integrins.
    Egesten A; Gullberg U; Olsson I; Richter J
    J Leukoc Biol; 1993 Mar; 53(3):287-93. PubMed ID: 8095965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eosinophil leukocyte degranulation in response to serum-opsonized beads: C5a and platelet-activating factor enhance ECP release, with roles for protein kinases A and C.
    Egesten A; Malm J
    Allergy; 1998 Nov; 53(11):1066-73. PubMed ID: 9860239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of human eosinophil activation by complement protein C5a and platelet-activating factor: similar functional responses are accompanied by different morphologic alterations.
    Zeck-Kapp G; Kroegel C; Riede UN; Kapp A
    Allergy; 1995 Jan; 50(1):34-47. PubMed ID: 7741187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-3 and IL-5 prime normal human eosinophils to produce leukotriene C4 in response to soluble agonists.
    Takafuji S; Bischoff SC; De Weck AL; Dahinden CA
    J Immunol; 1991 Dec; 147(11):3855-61. PubMed ID: 1940371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophils maintain their capacity to signal and release eosinophil cationic protein upon repetitive stimulation with the same agonist.
    Simon HU; Weber M; Becker E; Zilberman Y; Blaser K; Levi-Schaffer F
    J Immunol; 2000 Oct; 165(7):4069-75. PubMed ID: 11034418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the release of eosinophil cationic protein by eosinophil adhesion.
    Xu X; Håkansson L
    Clin Exp Allergy; 2000 Jun; 30(6):794-806. PubMed ID: 10848898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of some anti-asthma drugs on human eosinophil superoxide anions release and degranulation.
    Ezeamuzie CI; Al-Hage M
    Int Arch Allergy Immunol; 1998 Feb; 115(2):162-8. PubMed ID: 9482706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils.
    Kita H; Abu-Ghazaleh RI; Sur S; Gleich GJ
    J Immunol; 1995 May; 154(9):4749-58. PubMed ID: 7722326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of granule proteins from human eosinophils stimulated with mast-cell mediators.
    Takafuji S; Tadokoro K; Ito K; Nakagawa T
    Allergy; 1998 Oct; 53(10):951-6. PubMed ID: 9821474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of human lung fibroblasts on eosinophil degranulation.
    Takafuji S; Miyakuni Y; Nakagawa T; Shoji S; Murata S; Yamamoto K; Ito K
    Allergy; 2000 Dec; 55(12):1170-8. PubMed ID: 11117275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-activating factor induces mediator release by human basophils primed with IL-3, granulocyte-macrophage colony-stimulating factor, or IL-5.
    Brunner T; de Weck AL; Dahinden CA
    J Immunol; 1991 Jul; 147(1):237-42. PubMed ID: 1711077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of formoterol on platelet-activating factor induced eosinophil chemotaxis and degranulation.
    Eda R; Sugiyama H; Hopp RJ; Okada C; Bewtra AK; Townley RG
    Int Arch Allergy Immunol; 1993; 102(4):391-8. PubMed ID: 8241801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes.
    Rot A; Krieger M; Brunner T; Bischoff SC; Schall TJ; Dahinden CA
    J Exp Med; 1992 Dec; 176(6):1489-95. PubMed ID: 1281207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of rapamycin, cyclosporin A, and dexamethasone on interleukin 5-induced eosinophil degranulation and prolonged survival.
    Meng Q; Ying S; Corrigan CJ; Wakelin M; Assoufi B; Moqbel R; Kay AB
    Allergy; 1997 Nov; 52(11):1095-101. PubMed ID: 9404561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.